Inogen INGN
NASDAQ INGN
$5.61 +0.01 (+0.18%)
At close: Aug 21, 2026 · 4:00 PM EDT

Inogen (INGN) Non-Current Deffered Revenue (2013 - 2026)

Inogen (INGN) posted quarterly Non-Current Deffered Revenue of $3.2 million for Q1 2026, down 37.93% year-over-year from $5.1 million in Q1 2025, and down 12.02% quarter-over-quarter from $3.6 million in Q4 2025.

Inogen (INGN) Non-Current Deffered Revenue (2013 - 2026) Analysis & Trends

Inogen (INGN) has reported Non-Current Deffered Revenue for 14 consecutive years, with $3.2 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Non-Current Deffered Revenue fell 37.93% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $3.2 million (down 37.93% YoY), while the FY2025 annual figure was $3.6 million, down 37.31% from the prior year.
  • Non-Current Deffered Revenue eased to $3.2 million in Q1 2026 per INGN's latest filing, from $3.6 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $11.5 million in Q1 2022 and bottomed at $3.2 million in Q1 2026.
  • Historically, Non-Current Deffered Revenue has averaged $7.5 million across 5 years, with a median of $7.6 million in 2024.
  • Annual changes were most pronounced in 2022 — Non-Current Deffered Revenue fell 2.81% — and 2026, when it slumped 37.93%.
  • Inogen's Non-Current Deffered Revenue stood at $10.4 million in 2022, then slipped by 20.89% to $8.2 million in 2023, then plunged by 30.14% to $5.7 million in 2024, then slumped by 37.31% to $3.6 million in 2025, then declined by 12.02% to $3.2 million in 2026.
  • Business Quant data shows INGN's Non-Current Deffered Revenue at $3.2 million in Q1 2026, $3.6 million in Q4 2025, and $4.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn -
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn -
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn 539.34 Mn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn -
10 Inogen 152.26 Mn 46.72 Mn 43.27 Mn 2.86 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 2.86 Mn
Mar 31, 2026 3.17 Mn
Dec 31, 2025 3.60 Mn
Sep 30, 2025 4.08 Mn
Jun 30, 2025 4.59 Mn
Mar 31, 2025 5.11 Mn
Dec 31, 2024 5.75 Mn
Sep 30, 2024 6.44 Mn
Jun 30, 2024 7.07 Mn
Mar 31, 2024 7.61 Mn
Dec 31, 2023 8.23 Mn
Sep 30, 2023 8.88 Mn
Jun 30, 2023 9.35 Mn
Mar 31, 2023 9.80 Mn
Dec 31, 2022 10.40 Mn
Sep 30, 2022 11.03 Mn
Jun 30, 2022 11.40 Mn
Mar 31, 2022 11.51 Mn
Dec 31, 2021 11.86 Mn
Sep 30, 2021 12.14 Mn